1. Home
  2. All press releases

Innate Pharma announces its turnover for the first quarter of 2009 and updates on its cash situation

  • 2.5 million euros in turnover in the first quarter ending March 31, 2009
  • 35.4 million euros in cash and cash equivalent as at March 31, 2009 (excluding 4.4 million euros in research tax credit refunded in April 2009)
  • A total of 10.4 million euros in research tax credit refund since January 1, 2009
PR in english 42.6 KB
CP en français 43.03 KB